Guardant Health, Inc. (BMV:GH)
Mexico
· Delayed Price · Currency is MXN 820.00
0.00 (0.00%)
At close: May 12, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2014 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2014 - 2019 |
| Precision Oncology Testing |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology Testing Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Development Services and Other |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Development Services and Other Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gross Income by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2014 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2014 - 2019 |
| Precision Oncology Testing Gross Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology Testing Gross Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Development Services and Other Gross Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Development Services and Other Gross Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| United States | 733.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 29.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 40.57M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 4.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| Clinical Test Sales Volume | 218.80K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Test Sales Volume Growth | 25.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical Test Sales Volume | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceutical Test Sales Volume Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|